1. Home
  2. ICMB vs RGNT Comparison

ICMB vs RGNT Comparison

Compare ICMB & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

BUY

Current Price

$0.70

Market Cap

17.2M

Sector

Finance

ML Signal

BUY

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

BUY

Current Price

$1.30

Market Cap

14.3M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ICMB
RGNT
Founded
2013
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2M
14.3M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
ICMB
RGNT
Price
$0.70
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.3K
★ 32.5K
Earning Date
11-11-2026
09-11-2026
Dividend Yield
★ 21.53%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$5.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$1.23
52 Week High
$3.12
$15.50

Technical Indicators

Market Signals
Indicator
ICMB
RGNT
Relative Strength Index (RSI) 44.16 26.24
Support Level $0.65 $1.23
Resistance Level $0.88 $2.48
Average True Range (ATR) 0.06 0.10
MACD 0.00 -0.02
Stochastic Oscillator 54.31 0.00

Price Performance

Historical Comparison
ICMB
RGNT

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: